文献速递抗栓抗凝管理药物不良反应与药物警戒

HAS-BLED与ORBIT评分预测亚洲DOACs患者大出血的比较

Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants.
PubMed 文献 · Br J Clin Pharmacol · 2021-12-15

本研究在泰国10家三级医院回顾性纳入961例接受DOACs≥6个月的非瓣膜性房颤亚洲患者,比较HAS-BLED与ORBIT评分预测大出血的表现。

要点

  • HAS-BLED与ORBIT评分在亚洲DOACs患者中预测大出血性能相当,均为中等。
  • 基于既往华法林使用状态的分层分析与总体结果一致。

核心结论

  • HAS-BLED与ORBIT评分在亚洲NVAF接受DOACs患者中预测大出血均为中等性能,两者无显著差异。

主要发现

  • 平均随访1.55±1.13年,34例发生大出血(2.28事件/100患者年)。
  • 基于既往华法林使用状态的分析与总体队列一致。
  • 校准分析显示两评分均具有中等能力区分是否发生大出血。

临床怎么用

  • 在亚洲NVAF接受DOACs的患者中,HAS-BLED与ORBIT评分均可用于大出血风险分层,预测性能中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: This study aimed to evaluate the performance of HAS-BLED and ORBIT scores in predicting bleeding risk among Asian patients with nonvalvular atrial fibrillation (NVAF) using direct-acting oral anticoagulants (DOACs). METHODS: A retrospective chart review was conducted among adult patients receiving DOACs for ≥6 months during January 2013 to December 2017 in 10 tertiary care hospitals in Thailand. The area under the receiver operating curve (AUROC) method or C-statistic was used to test the diagnostic accuracy for bleeding risk classification of HAS-BLED and ORBIT scores. The predictive performances of the two scores were compared using DeLong's method. RESULTS: A total of 961 NVAF patients, 52.5% warfarin-naïve and 47.5% warfarin-experienced, with mean age of 74.25 ± 10.08 years, were included in the analysis. Mean HAS-BLED and ORBIT scores of the cohort were 1.98 ± 1.10 and 2.37 ± 1.71, respectively. During the mean follow-up time of 1.55 ± 1.13 years, 34 patients experienced major bleeding (2.28 events/100 patient-year). For the overall cohort, both the HAS-BLED and ORBIT scores showed similarly moderate predictive performance on bleeding with C-statistic (95% confidence interval) of 0.65 (0.57-0.74) and 0.64 (0.56-0.71), respectively. There was no statistical significance between the two scores (P = .62). Analysis based on the status of previous warfarin use was consistent with the overall cohort. Based on the calibration analysis, both HAS-BLED and ORBIT scores possessed moderate ability to identify those who experienced major bleeding from those who did not. CONCLUSION: Both HAS-BLED and ORBIT bleeding risk scores had moderate predictive performance in Asian NVAF patients receiving DOACs.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wattanaruengchai P, Nathisuwan S, Karaketklang K, et al. Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants. Br J Clin Pharmacol. 2021. PMID: 34783372. doi:10.1111/bcp.15145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。